Aller au contenu principal
Fermer
  2. Aide
  2. Aide

Transgene to Participate in Upcoming Investor Meetings
information fournie par Boursorama CP 07/04/2026 à 17:45

Ajouter Boursorama à vos sources

Strasbourg, France, April 7, 2026, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will meet institutional investors during the upcoming editions of:

- Investor Access Event (by Allinvest Securities), on April 9, 2026, in Paris (France);
- Life Sciences Conference (by Van Lanschot Kempen), on April 16, 2026, in Amsterdam (Netherlands).

Next financial communications:
- April 29, 2026: First Quarter 2026 Financial Results
- May 22, 2026: Annual Shareholders’ Meeting


.../...

Valeurs associées

TRANSGENE
0,6900 EUR Euronext Paris -0,43%

0 commentaire

Signaler le commentaire

Fermer

A lire aussi

Mes listes

valeur

dernier

var.
Pétrole Brent
104,23 -1,77%
CAC 40
7 873,11 +0,58%
EUR/USD SPOT
1,12255 +0,61%
Or
4 143,7 +0,93%
TOTALENERGIES
80,17 +0,35%
Chargement...

Pages les plus populaires

L'offre BoursoBank